Mantle cell lymphoma digital illustration

Mantle cell lymphoma Save


ICD-10 code: C83.1

Chapter: Neoplasms

Mantle Cell Lymphoma: Symptoms, Causes, and Treatment

Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin's lymphoma that affects the lymphatic system. It is characterized by the uncontrolled growth of abnormal B-cells in the mantle zone of the lymph nodes, which is why it is called mantle cell lymphoma.

The cause of MCL is not known, but it is more common in men than in women and usually affects people over the age of 60. The symptoms of MCL include swollen lymph nodes, fatigue, weight loss, and fever.

  1. Diagnosis: To diagnose MCL, a doctor will perform a physical exam, blood tests, and a biopsy of the lymph nodes.
  2. Treatment: Treatment options for MCL include chemotherapy, radiation therapy, stem cell transplantation, and targeted therapy. The choice of treatment depends on the stage of the disease and the patient's overall health.
  3. Prognosis: The prognosis for MCL varies depending on the stage of the disease at the time of diagnosis. Early-stage MCL has a better prognosis than advanced-stage MCL.

Patients with MCL should work closely with their healthcare team to create a treatment plan that is customized to their individual needs. It is important to follow the treatment plan closely and to keep all follow-up appointments to monitor the progress of the disease.

In summary, mantle cell lymphoma is a rare form of non-Hodgkin's lymphoma that affects the lymphatic system. It is more common in men than in women and usually affects people over the age of 60. The symptoms of MCL include swollen lymph nodes, fatigue, weight loss, and fever. Treatment options for MCL include chemotherapy, radiation therapy, stem cell transplantation, and targeted therapy. The prognosis for MCL varies depending on the stage of the disease at the time of diagnosis.